A breakthrough in the quest to find a blood test for Alzheimer's will help doctors and patients "manage the disease", one of the researchers has said.
Professor Howard Federoff explained:
Our novel blood test offers the potential to identify people at risk for progressive cognitive decline and can change how patients, their families and treating physicians plan for and manage the disorder.
The preclinical state of the disease offers a window of opportunity for timely disease-modifying intervention.
Biomarkers such as ours that define this asymptomatic period are critical for successful development and application of these therapeutics.
We consider our results a major step toward the commercialisation of a preclinical disease biomarker test.
More top news
The contract that set the Beatles on their way to superstardom is to go up for sale for the first time, and could fetch as much as £500,000.
The shortest man ever to have been measured has died aged 75, Guinness World Records has announced.
Britons have stepped forward to offer help to refugees after a photo of a drowned three-year-old boy prompted an outpouring of support.